Uncategorized
Preliminary phase 4 study data show good results of Jetrea in specific group of patients
PARIS — A multicenter phase 4 study evaluated the functional and anatomic outcomes of Jetrea in patients with focal vitreomacular traction and no epiretinal membranes. “Previous phase 3 studies demonstrated that best responders fell within these two categories, and it was thanks to the results of this group of patients that the ocriplasmin could be registered,” Laurent Kodjikian, MD, said at the meeting of the French Society of Ophthalmology.